Dapsone hypersensitivity syndrome in an adolescent during treatment of leprosy

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 46, Issue 6, 2004, Pages 331-334

  Bucaretchi, Fábio ^a   Vicente, Danielly C ^a   Pereira, Ricardo M ^a   Tresoldi, Antonia T ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Dapsone syndrome; Hepatic failure, Leprosy; Sulfone syndrome

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CLOFAZIMINE; DAPSONE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; RIFAMPICIN;

ACUTE KIDNEY FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ANKLE EDEMA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTEREMIA; BLOOD COMPONENT; CASE REPORT; CHILD; CHOLESTASIS; CONJUNCTIVITIS; DAPSONE HYPERSENSITIVITY SYNDROME; DETERIORATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; EXFOLIATIVE DERMATITIS; FACE EDEMA; FEMALE; FEVER; FLUID THERAPY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROINTESTINAL HEMORRHAGE; HAND DISEASE; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL STANDARD UNIT; JAUNDICE; LEPROSY; LEUKOCYTE COUNT; LIVER FAILURE; LIVER TOXICITY; LYMPHADENOPATHY; MOUTH LESION; MULTIBACILLARY LEPROSY; PANCYTOPENIA; PNEUMONIA; PREVALENCE; RARE DISEASE; RASH; SHOCK; SIDE EFFECT; THROMBOCYTE COUNT; URINARY TRACT INFECTION;

EID: 11144234239     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0036-46652004000600006     Document Type: Article

References (26)

1. ALDDAY, E.J. & BARNES, J. - Toxic effects of diaminodiphenylsulphone in leprosy. Lancet, 2: 205-206, 1951.
2. ANDRADE, Z.M.V.; FRANÇA E.R.; TEIXEIRA, M.A.G. & SANTO, I.B. - Síndrome sulfônica: relato de um caso. An. bras. Derm., 74: 59-61, 1999.
3. BARBOSA, A.M.: MARTINS JUNIOR, E.; FLEURY, R.N. & OPROMOLLA, D.V.A. - Mais um caso de síndrome da sulfona. Hansenol. Int., 25: 159-162, 2000.
4. BLUHM, R.E.; ADEDOYIN, A.; McCARVER, D.G. & BRANCH, R.A. - Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors. Clin. Pharmacol. Ther., 65: 598-605, 1999.
5. BOCQUET, H.; BOURGAULT-VILLADA, I.; DELFAU-LARUE, M.H. et al. - Syndrome d'hypersensibilité à la dapsone. Clone T circulant transitoire. Ann. Derm. Vénér., 122: 514-516, 1995.
6. BRASIL, M.T.L.R.F.; OPROMOLLA, D.V.; MARZLIAK, M.L.C. & NOGUEIRA, W. - Results of a surveillance system for adverse effects in leprosy's WHO/MDT. Int. J. Leprosy, 64: 97-104, 1996.
7. CHALASANI, P.; BAFFOE-BONNIE, H. & JURADO, R.I. - Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient. Sth. med. J., 87: 1145-1146, 1994.
8. FREY, H.M.; GERSHON, A.A.; BORKOWSKY, W. & BULLOCK, W.E. - Fatal reaction to dapsone during treatment of leprosy. Ann. intern. Med., 94: 777-779, 1981.
9. GALLO, M.E.N.; NERY, J.A.C. & GARCIA, C.G. - Interconências pelas drogas utilizadas nos esquemas poliquimioterápicos em hanseníase. Hansenol. Int., 20: 46-50, 1995.
10. JOHNSON, D.A.; CATTAU Jr., E.L.; KURlTSKY, J.N. & ZIMMERMAN, H.J. - Liver involvement in the sulfone syndrome. Arch. intern. Med., 146: 875-877, 1986.
11. KALUARACHCHI, S.I.; FERNANDOPULLE, B.M. & GUNAWARDANE, B.P. - Hepatic and haematological adverse reactions associated with the use of multidrug therapy in leprosy: a five year retrospective study. Indian J. Leprosy, 73: 121-129, 2001.
12. KUMAR, R.H.; KUMAR, M.V. & THAPPA, D.M. - Dapsone syndrome: a five year retrospective analysis. Indian J. Leprosy, 70: 271-276, 1998.
13. LASTÓRIA, J.C.; DE MELLO, M.S.; PUTINATTI, A. & SOUZA, V. - Síndrome de hipersensibilidade à dapsona. Diagn. Tratam., 9: 19-21, 2004.
14. LETA, G.C.; SIMAS, M.E.P.A.S.; OLIVEIRA, M.L.W. & GOMES, M.K. - Síndrome de hipersensibilidade à dapsona: revisão sistemática dos critérios diagnósticos. Hansenol. Int., 28: 79-84, 2003.
15. LOWE, J. - Treatment of leprosy with diamino diphenylsulphone by mouth. Lancet, 1: 145-150, 1950.
16. MANDELL, G.L. & PETRI Jr., W.A. - Drugs used in the chemotherapy of tuberculosis, Mycobacterium avlum complex disease and leprosy. In: HARDMAN, J.G.; LIMBIRD, L.E.; MOLINOFF, P.B.; RUDDON, R.W. & GILMAN, A.G., ed. Goodman & Gilman's pharmacological basis of therapeutics. 9. international ed. New York, McGraw Hill, 1996. p. 1155-1174.
17. OPROMOLLA, D.V.A. & FLEURY, R.N. - Sindrome da sulfona e reação reversa. Hansenol. Int., 19: 70-76, 1994.
18. PRUSSIK, R. & SHEAR, N.H. - Dapsone hypersensitivity syndrome. J. Amer. Acad. Derm., 35: 346-349, 1996.
19. RAO, P.N. & LAKSHMI, T.S. - Increase in the incidence of dapsone hypersensitivity syndrome: an appraisal. Leprosy Rev., 72: 57-62, 2001.
20. REEVE, P.A.; ALA, J.L. & HALL, J.J. - Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy. J. trop. Med. Hyg., 95: 266-270, 1992.
21. RISSE, L.; BERNARD, P.; BROSSET, A. et al - Syndrome d'hypersensibilitȩ a la disulone®. Ann. Derm. Vȩnȩr., 121: 242-244, 1994.
22. SAITO, S.; IKEZAWA, Z.; MIYAMOTO, H. & KIM, S. - A case of dapsone syndrome. Clin. exp. Derm., 19: 152-156, 1994.
23. SANTOS, M.E.; LETA, G.C.; OLIVEIRA, M.L.W. et al. - Dapsone hypersensitivity syndrome (DHS): not so rare to be minimized in endemic countries. In: INTERNATIONAL LEPROSY CONGRESS, 16, Salvador, Brazil, 2002. Book of abstracts, PT 16.
24. THONG, B.Y.; LEONG, K.P. & CHNG, H.H. - Hypersensitivity syndrome associated with dapsone/pyrimethamine (Maloprim) antimalaria chemoprophylaxis. Ann. Allergy Asthma Immunol., 88: 527-529, 2002.
25. TOMECKI, K.J & CATALANO, C.J. - Dapsone hypersensitivity. The sulfone syndrome revisited. Arch. Derm., 117: 38-39, 1981.
26. WHO. Leprosy Elimination Project. Status Report, 2003. WHO, Geneva, 2004. http://www.who.int/lep/Reports/s20042.pdf. Accessed: 01/03/2004.